CLINICAL TRIALS PROFILE FOR LEVOCETIRIZINE DIHYDROCHLORIDE
✉ Email this page to a colleague
All Clinical Trials for levocetirizine dihydrochloride
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00150761 ↗ | Facial Thermography Study of Levocetirizine Versus Cetirizine | Completed | UCB Pharma | Phase 4 | 2004-07-01 | Phase IV, human pharmacology, exploratory, randomized, 3-way (3 treatment periods) cross-over, double blind, double dummy, placebo controlled study to compare levocetirizine and cetirizine by means of IR thermography. |
| NCT00152412 ↗ | Open Study to Evaluate the Safety of Levocetirizine in Young Children (2 - 6 Years) Suffering From Allergic Rhinitis | Completed | UCB Pharma | Phase 2 | 2004-06-01 | 4 week open study to evaluate the safety of levocetirizine in young children (2 - 6 years) suffering from allergic rhinitis. As secondary objective, this study will assess the efficacy of the treatment by means of the T4SS (Total 4 symptoms scores of allergic rhinitis) and each of the 4 individual rhinitis symptom scores |
| NCT00152464 ↗ | Prevention of Asthma With Levocetirizine 18 Month Treatment in Infants (12 - 24 Months) Suffering From Eczema (Atopic Dermatitis) and Sensitized to Grass Pollen and/or House Dust Mite (HDM) | Completed | UCB Pharma | Phase 3 | 2002-03-20 | The Early Prevention of Asthma in Atopic Children (EPAAC™). 24 months study to evaluate the efficacy and safety of levocetirizine (LCTZ) in preventing the onset of asthma in 12 to 24 months old children. |
| NCT00152464 ↗ | Prevention of Asthma With Levocetirizine 18 Month Treatment in Infants (12 - 24 Months) Suffering From Eczema (Atopic Dermatitis) and Sensitized to Grass Pollen and/or House Dust Mite (HDM) | Completed | UCB Pharma SA | Phase 3 | 2002-03-20 | The Early Prevention of Asthma in Atopic Children (EPAAC™). 24 months study to evaluate the efficacy and safety of levocetirizine (LCTZ) in preventing the onset of asthma in 12 to 24 months old children. |
| NCT00160537 ↗ | POPULAR (Preference Of Patient Using Levocetirizine in Allergic Rhinitis) | Completed | UCB Pharma | Phase 4 | 2005-05-01 | Comparative study on clinical efficacy and safety of levocetirizine and desloratadine as measured by the subject's satisfaction/dissatisfaction after one week of treatment |
| NCT00160563 ↗ | Prevention of Asthma With Levocetirizine (36 Month Treatment) in Young Children Suffering From Eczema (Atopic Dermatitis) and Sensitized to Grass Pollen and House Dust Mite and Having Completed the Previous EPAAC Trial (NCT00152464) | Terminated | UCB Pharma | Phase 3 | 2004-06-01 | Prolongation of the EPAAC™ trial - NCT00152464 (The Early Prevention of Asthma in Atopic Children). 36 months study to evaluate the efficacy and safety of levocetirizine (LCTZ) in preventing the onset of asthma in young atopic children. |
| NCT00160589 ↗ | LEADER (LEvocetirizine And DEsloratadine in Allergic Rhinitis) | Completed | UCB Pharma | Phase 4 | 2005-04-01 | Two weeks study to evaluate the efficacy and safety of Levocetirizine and Desloratadine in patients suffering from Allergic Rhinitis (AR) |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for levocetirizine dihydrochloride
Condition Name
Clinical Trial Locations for levocetirizine dihydrochloride
Trials by Country
Clinical Trial Progress for levocetirizine dihydrochloride
Clinical Trial Phase
Clinical Trial Sponsors for levocetirizine dihydrochloride
Sponsor Name
